Relative levels of transcripts after DHMEQ treatment
Gene, by family name . | Ratio . |
---|---|
Caspase | |
Caspase-3 | 1.61 |
Caspase-8 | 1.21 |
Caspase-9 | 2.01 |
Bcl | |
Bcl-xL | −1.43 |
Bcl-2 | −1.40 |
Bad | −1.12 |
BAK | 1.79 |
Bid | 1.10 |
CARD | |
clAP-1 | −1.91 |
clAP-2 | −2.78 |
Apaf-1 | 1.12 |
Bcl10 | 1.20 |
TRAF | |
TRAF2 | −1.14 |
TRAF5 | −1.03 |
TRAF6 | 1.00 |
TNF/TNFR | |
TNF-α | −1.16 |
TNFR2 | −1.30 |
FAS | −2.01 |
Rel and related | |
NFKB1 | −1.97 |
NFKB2 | −1.43 |
IKBα | −2.34 |
IKBβ | −1.04 |
IKKα | −1.07 |
IKKβ | −1.94 |
IKKγ | 1.30 |
Cyclin | |
Cyclin A1 | 1.29 |
Cyclin B1 | 1.05 |
Cyclin B2 | −1.31 |
Cyclin C | −1.08 |
Cyclin D1 | −1.60 |
Cyclin D2 | −6.34 |
Cyclin E1 | −3.00 |
Others | |
Myc | −1.48 |
TP53 | −1.20 |
RBI | −3.79 |
Gene, by family name . | Ratio . |
---|---|
Caspase | |
Caspase-3 | 1.61 |
Caspase-8 | 1.21 |
Caspase-9 | 2.01 |
Bcl | |
Bcl-xL | −1.43 |
Bcl-2 | −1.40 |
Bad | −1.12 |
BAK | 1.79 |
Bid | 1.10 |
CARD | |
clAP-1 | −1.91 |
clAP-2 | −2.78 |
Apaf-1 | 1.12 |
Bcl10 | 1.20 |
TRAF | |
TRAF2 | −1.14 |
TRAF5 | −1.03 |
TRAF6 | 1.00 |
TNF/TNFR | |
TNF-α | −1.16 |
TNFR2 | −1.30 |
FAS | −2.01 |
Rel and related | |
NFKB1 | −1.97 |
NFKB2 | −1.43 |
IKBα | −2.34 |
IKBβ | −1.04 |
IKKα | −1.07 |
IKKβ | −1.94 |
IKKγ | 1.30 |
Cyclin | |
Cyclin A1 | 1.29 |
Cyclin B1 | 1.05 |
Cyclin B2 | −1.31 |
Cyclin C | −1.08 |
Cyclin D1 | −1.60 |
Cyclin D2 | −6.34 |
Cyclin E1 | −3.00 |
Others | |
Myc | −1.48 |
TP53 | −1.20 |
RBI | −3.79 |
CARD indicates caspase recruitment domain; TRAF, TNF receptor (TNFR)-associated factor.